Washington Trust Bank’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-21
Closed -$1K 980
2016
Q4
$1K Hold
21
﹤0.01% 925
2016
Q3
$1K Sell
21
-38
-64% -$1.86K ﹤0.01% 990
2016
Q2
$3K Hold
59
﹤0.01% 708
2016
Q1
$2K Sell
59
-91
-61% -$3.35K ﹤0.01% 721
2015
Q4
$5K Hold
150
﹤0.01% 660
2015
Q3
$5K Hold
150
﹤0.01% 685
2015
Q2
$6K Buy
+150
New +$5.46K ﹤0.01% 711
2015
Q1
Sell
-750
Closed -$29K 873
2014
Q4
$29K Hold
750
0.01% 562
2014
Q3
$27K Sell
750
-200
-21% -$7.43K 0.01% 556
2014
Q2
$37K Buy
950
+100
+12% +$3.74K 0.01% 534
2014
Q1
$31K Buy
+850
New +$31K 0.01% 551

Other funds holding XYL

Washington Trust Bank's XYL Position: Q1 2017 in Review

Washington Trust Bank sold out of Xylem (XYL) in Q1 2017, closing a stake of 21 shares — an estimated $1K sold.

Washington Trust Bank first reported a position in XYL in Q1 2014 and held it in 11 quarters. The position peaked at $37K in Q2 2014. 547 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

  • Washington Trust Bank reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
  • Washington Trust Bank sold 21 Xylem shares in Q1 2017, an estimated $1K.
  • Washington Trust Bank first reported a position in Xylem in Q1 2014 and held it in 11 quarters.
  • Washington Trust Bank's Xylem position peaked at $37K in Q2 2014.
  • 547 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on Washington Trust Bank's 13F filing for Q1 2017, filed 18 Apr 2017.